Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Dr Lalchandani Labs's Enterprise Value is ₹133.72 Mil.
Dr Lalchandani Labs's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 was ₹-1.68 Mil. Therefore, Dr Lalchandani Labs's EV-to-EBIT ratio for today is -79.40.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Dr Lalchandani Labs's Enterprise Value is ₹133.72 Mil.
Dr Lalchandani Labs's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 was ₹4.98 Mil. Therefore, Dr Lalchandani Labs's EV-to-EBITDA ratio for today is 26.86.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Dr Lalchandani Labs's Enterprise Value is ₹133.72 Mil.
Dr Lalchandani Labs's Revenue for the trailing twelve months (TTM) ended in Sep. 2023 was ₹54.82 Mil. Therefore, Dr Lalchandani Labs's EV-to-Revenue ratio for today is 2.44.
Dr Lalchandani Labs Enterprise Value Historical Data
The historical data trend for Dr Lalchandani Labs's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Dr Lalchandani Labs's Enterprise Value
For the Diagnostics & Research subindustry, Dr Lalchandani Labs's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dr Lalchandani Labs's Enterprise Value Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Dr Lalchandani Labs's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Dr Lalchandani Labs's Enterprise Value falls into.
Dr Lalchandani Labs Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Dr Lalchandani Labs's Enterprise Value for the fiscal year that ended in Mar. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dr Lalchandani Labs (BOM:541299) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Dr Lalchandani Labs's current Enterprise Value is ₹133.72 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Dr Lalchandani Labs's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 was ₹-1.68 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Dr Lalchandani Labs's current Enterprise Value is ₹133.72 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Dr Lalchandani Labs's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 was ₹4.98 Mil.
Dr Lalchandani Labs's current Enterprise Value is ₹133.72 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Dr Lalchandani Labs's Revenue for the trailing twelve months (TTM) ended in Sep. 2023 was ₹54.82 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dr Lalchandani Labs Enterprise Value Related Terms
Thank you for viewing the detailed overview of Dr Lalchandani Labs's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Dr Lalchandani Labs (BOM:541299) Business Description
Dr Lalchandani Labs Ltd engages in the business of running laboratories for carrying out pathological investigations of various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immunology, virology, cytology, and other pathological and radiological investigations. It also offers Immunoassay, Immuno-Histochemistry, Molecular Pathology, DNA, and Genetic Testing. The company operates in two segments B2B sales and B2C sales, out of which the majority is from B2C sales. Revenue is generated from the sale of services.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BOM:541299 has been successfully added to your 